News - Hikma Pharmaceuticals, Laboratoires Majorelle

Filter

Popular Filters

1 to 25 of 26 results

Hikma delivers group revenue growth of 23% and EPS up 111% for 2013

Hikma delivers group revenue growth of 23% and EPS up 111% for 2013

12-03-2014

Jordon-headquartered Hikma Pharmaceuticals today reported its preliminary results for the year ended…

FinancialGenericsHikma Pharmaceuticals

Hikma in $40 million deal to enhance delivery of generic injectables

20-11-2013

USA-based Unilife Corp has signed a long-term commercial supply contract with Jordan-headquartered Hikma…

GenericsHikma PharmaceuticalsLicensingMarkets & MarketingUnilife Corp

Majorelle to market Apricus’ ED product in France, Monaco and certain African countries

13-11-2013

USA-based Apricus Biosciences has signed an exclusive license agreement with Laboratoires Majorelle,…

Apricus BioscienceEuropeLaboratoires MajorelleLicensingMen's HealthPharmaceuticalRest of the WorldVitaros

Hikma sets up JV for entering Ethiopian pharma market

Hikma sets up JV for entering Ethiopian pharma market

18-09-2013

Jordon-headquartered drugmaker Hikma Pharmaceuticals (LSE: HIK) says that it has signed a 50:50 joint…

GenericsHikma PharmaceuticalsMarkets & MarketingMergers & AcquisitionsMIDROC PharmaceuticalsRest of the World

Hikma first half EPS beats expectations; raises guidance

21-08-2013

Jordan-headquartered drugmaker Hikma Pharmaceuticals (HIK: LSE) this morning (August 21) reported financial…

FinancialGenericsHikma PharmaceuticalsPharmaceutical

Jordon's Hikma upgrades 2013 guidance

08-07-2013

Jordon-based Hikma Pharmaceuticals (LSE: HIK) has issued an upgraded guidance for 2013, saying that its…

FinancialGenericsHikma Pharmaceuticals

Hikma licenses Vibativ from Theravance for MENA region

02-07-2013

Jordon-headquartered Hikma Pharmaceuticals (LSE: HIK) says it has signed an exclusive commercialization…

Antibiotics and Infectious diseasesHikma PharmaceuticalsLicensingPharmaceuticalRest of the WorldTheravanceVibativ

Hikma to retain its global Injectables business

17-04-2013

Further to its announcement last month that it was undertaking a review of the strategic options for…

FinancialGenericsHikma PharmaceuticalsMergers & AcquisitionsPharmaceutical

Sinclair IS in Flammacerium deal with Hikma; sells Fazol G to Majorelle

19-03-2013

UK specialty pharma firm Sinclair IS Pharma (AIM: SPH.L) and Jordon-headquartered Hikma Pharmaceuticals…

Antibiotics and Infectious diseasesFazol GHikma PharmaceuticalsLaboratoires MajorelleLicensingPharmaceuticalSinclair IS PharmaWomen's Health

Hikma delivers revenue growth of 21% and EPS up 24% for 2012

13-03-2013

Jordon-headquartered Hikma Pharmaceuticals (LSE: HIK) has reported preliminary results for 2012, showing…

FinancialGenericsHikma PharmaceuticalsPharmaceutical

Hikma leaps as it confirms unsolicited interest in Injectables business

04-03-2013

Jordanian drugmaker Hikma Pharmaceuticals (LSE: HIK) saw its shares jump 8.1% to£9.365 on Friday,…

FinancialGenericsHikma PharmaceuticalsMergers & AcquisitionsPharmaceutical

Hikma to buy Egyptian pharma company for around $20 million

10-01-2013

Fast-growing Jordan-headquartered drugmaker Hikma Pharmaceuticals (LSE: HIK) says it has agreed to acquire…

Egyptian Company for Pharmaceuticals & ChemicGenericsHikma PharmaceuticalsMergers & AcquisitionsPharmaceuticalRest of the World

Hikma signs deal with GP Pharma for Lutrate 1 month in MENA region

22-10-2012

Jordanian drugmaker Hikma Pharmaceuticals (LSE: HIK) has signed a license and supply agreement for the…

GenericsGP PharmHikma PharmaceuticalsLicensingLutrateOncologyRest of the World

Solid first-half 2012 results from Jordan's Hikma

16-08-2012

Fast-growing Jordan headquartered Hikma Pharmaceuticals (LSE: HIK) has reported its interim results for…

FinancialGenericsHikma PharmaceuticalsPharmaceutical

Hikma may invest $100 million in Ukrainian pharma market

15-05-2012

Hikma Pharmaceuticals (LSE: HIK), Jordan's largest pharmaceutical company which is listed on the London…

EuropeFinancialGenericsHikma Pharmaceuticals

Hikma earnings down despite 25.6% revenue growth

14-03-2012

Fast-growing Jordan headquartered drugmaker Hikma Pharmaceuticals (LSE: HIK) delivered what it called…

FinancialGenericsHikma PharmaceuticalsPharmaceutical

Hikma adds to stake in Promopharm; gets US appro for argatroban

22-01-2012

Fast-growing Jordan headquartered Hikma Pharmaceuticals (LSE: HIK) says that it has increased its stake…

ArgatrobanCardio-vascularGenericsHikma PharmaceuticalsMergers & AcquisitionsNorth AmericaPharmaceuticalPromopharmRegulationRest of the World

AEterna Zentaris signs up Hikma to commercialize perifosine in MENA region

24-11-2011

Canada’s AEterna Zentaris (TSX: AEZ) has signed an exclusive commercialization and licensing agreement…

AEterna ZentarisGenericsHikma PharmaceuticalsLicensingOncologyperifosinePharmaceuticalRest of the World

Hikma enters Moroccan market via $111 million controlling stake in Promopharm

05-10-2011

Jordan-headquartered Hikma Pharmaceuticals (LSE: HIK) says that it has acquired 63.9% of Promopharm (Societe…

GenericsHikma PharmaceuticalsMergers & AcquisitionsPharmaceuticalPromopharmRest of the World

Hikma unit to increase focus on contract manufacturing, aimed at alleviating US drug shortages

20-09-2011

Jordan-headquartered Hikma Pharmaceuticals (LSE: HIK) says that its US subsidiary, West-Ward, is to focus…

GenericsHikma PharmaceuticalsMarkets & MarketingNorth AmericaWest-Ward

Jordan’s Hikma delivers 10.4% sales growth in first half 2011

25-08-2011

Jordon-headquartered Hikma Pharmaceuticals (LSE: HIK) has reported interim results for the six months…

FinancialGenericsHikma PharmaceuticalsPharmaceutical

Vifor Pharma ties up with Hikma for Ferinject in Middle East and North Africa

17-08-2011

Switzerland-based Vifor Pharma, a subsidiary of the Galenica Group (GALN: SIX), has entered into a collaboration…

FerinjectFinancialGalenicaHikma PharmaceuticalsLicensingPharmaceuticalRest of the WorldVifor Pharma

Hikma takes stake in China’s Hubei Haosun to enhance API sourcing

11-07-2011

Fast-growing Jordan-headquartered drugmaker Hikma Pharmaceuticals (LSE: HIK) says that it has acquired…

GenericsHikma PharmaceuticalsHubei HaosunMergers & AcquisitionsOncology

1 to 25 of 26 results

Back to top